Find a trial

ARTEMIDE-Lung02 / D702BC00001

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Locations Townsville, Southport

Diagnosis Lung cancer

ARTEMIDE-Lung03 / D702FC00001

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-squamous NSCLC

Locations Townsville, Southport

Diagnosis Lung cancer

PRIME_LUNG

Primary Radiotherapy In MEtastatic Lung Cancer – A Pilot Study

Locations Gold Coast University Hospital

Diagnosis Lung cancer

SUNRAY-01 / J3M-MC-JZQB

Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Locations Wesley

Diagnosis Lung cancer

SUNRAY-02 / J3M-MC-JZQH

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

Locations Adelaide, Wesley

Diagnosis Lung cancer

BNT327-03

Safety and Effectiveness of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

Locations Adelaide

Diagnosis Lung cancer